PRF1 and neoplasm: The second check-point corresponds to the so called “effector phase”, during which, the mature cytotoxic T-lymphocytes react directly with the TAA-exposing tumor cells, leading to their death by releasing granzyme, perforines or by linking the FAS-receptors expressed on the tumor cells surface, and ultimately inducing apoptosis [13,14].